DeepSeek: Good or Bad for the AI Ecosystem?
By

In January 2025, China-founded DeepSeek announced the release of its R1 Large Language Model (LLM), which has massively disrupted global markets. DeepSeek’s R1 self-reported training cost was under $6 million, a tiny fraction of the billions America’s Silicon Valley companies spend to build their AI models. The result: Tech stocks…Read More

Read More
Optimizing the Collective Finance Function: A Strategic Assessment Approach
By

One of the most common challenges I encounter as a finance executive is assessing the collective finance function within an organization and making strategic recommendations for improvement. This process involves a detailed, structured evaluation of Finance, Accounting/Tax/Treasury, and Investor Relations, ensuring that the right people, processes, and strategies are in…Read More

Read More
A Guide to DeepSeek’s Revolutionary Approach
By

Are you just getting used to ChatGPT? Well, now there’s a new game in town, and it’s growing its 1.8M daily user base fast. DeepSeek entered the AI landscape in the second half of 2023, but it disrupted global markets on January 20, 2025. This is when DeepSeek released its…Read More

Read More
The 2025 BioPharma & MedTech IPO Landscape
By

With Highlights from the JP Morgan Healthcare Conference To understand the current IPO landscape of BioPharma and MedTech, let’s go straight to the data: There were 15 IPOs globally in 2024; 10 in 2023, and 25 in 2022 for MedTech companies. MedTech IPO activity peaked in 2021 with 61 companies…Read More

Read More

More Posts